ABT-333 (deleobuvir)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABT-333 (deleobuvir), covering 2015-01-08 to 2015-01-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-333 and Ribavirin (RBV) in Treatment-Naïve and Non-responder Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection [Phase 2]